Aug. 7 (UPI) -- U.S. pharma company Pfizer said Friday it will manufacture and supply the antiviral drug remdesivir for use in COVID-19 patients, as part of a multi-year agreement with Gilead Sciences.
Originally developed by Gilead to treat viruses like Ebola, remdesivir has demonstrated it can lower the risk of death in COVID-19 patients.